Merck & Company NYSE: MRK
Merck & Co., Inc. provides healthcare solutions worldwide in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.
Name | Merck & Company |
Ticker | MRK |
Exchange | NYSE |
Sector | Health Care |
Industry | Drug Manufacturers - Diversified |
Price
52W Low/High |
72.62
66.40 / 86.93 |
Momentum | Weak Down |
Market cap | 184 B |
1Y Total Return |
-1.91%
Weak |
1Y Volatility |
31.88%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Merck & Co., Inc. provides healthcare solutions worldwide in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.
Details
Ticker | MRK |
Name | Merck & Company |
ISIN | US58933Y1055 |
CUSIP | 58933Y105 |
Exchange | NYSE |
Sector | Health Care |
Industry | Drug Manufacturers - Diversified |
Country | USA |
Currency | U.S. Dollar |
Share as of 2/26/21
Close Price | 72.62 |
52W Low/High | 66.40 / 86.93 |
Market cap | 184 B |
1Y Total Return |
-1.91%
Weak |
1Y Volatility |
31.88%
Low Risk |
Beta | 0.98 |
PE (trailing) |
16.07
Below Average |
12M Dividends | 2.44 |
Last Dividend Date | 12/14/20 |
Dividend Yield | 3.36% |
Fin. Strength
Net Profit Margin | 24.3% |
Cash from Op. / Cur. Liabilities | 0.54 |
Diluted Earnings / Share | 4.52 |
ROE | 41.1% |
ROIC | 19.1% |
Price / Revenue | - |
Price / Book | - |
Price / CF | - |
Current Ratio | 1.3 |
Cur.Liabilities / Tot.Liabilities | 0.3 |
Financial Leverage | 0.98 |
in Mils USD |
rolling-year up to September
|
||||||
---|---|---|---|---|---|---|---|
Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Revenue |
47,348
|
45,971
|
41,729
|
39,804
|
39,907
|
39,765
|
|
Gross Profit |
33,727
|
32,239
|
28,069
|
26,861
|
25,498
|
24,932
|
|
R&D |
10,270
|
9,538
|
9,853
|
12,811
|
7,272
|
7,190
|
|
EBITDA |
17,214
|
15,113
|
12,633
|
7,957
|
12,659
|
22,762
|
|
Operating Income |
12,722
|
11,750
|
7,315
|
3,036
|
7,823
|
6,385
|
|
Net Income exc. Extra |
11,518
|
9,313
|
3,347
|
2,846
|
5,491
|
10,782
|
|
per Share | |||||||
Diluted avg Shares |
-
|
-
|
-
|
-
|
-
|
-
|
|
EPS exc. Extra |
4.52
|
3.58
|
1.25
|
1.04
|
1.95
|
3.71
|
|
Dividend |
2.44
|
2.20
|
1.92
|
1.88
|
1.84
|
1.80
|
|
Div. Yield (an.) |
2.94%
|
2.61%
|
2.71%
|
2.94%
|
2.95%
|
3.64%
|
|
Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Total Assets |
89,800
|
83,331
|
85,130
|
91,676
|
98,335
|
101,232
|
|
Cash, Eq & Invt ShortTerm |
7,356
|
8,018
|
10,285
|
11,195
|
13,067
|
12,089
|
|
Total Current Assets |
26,577
|
26,142
|
26,836
|
27,919
|
29,440
|
28,567
|
|
Total Non-Current Assets |
63,223
|
57,189
|
58,294
|
63,757
|
68,895
|
72,665
|
|
Intangibles |
36,925
|
31,787
|
30,433
|
33,478
|
38,766
|
41,485
|
|
Total Liabilities |
60,530
|
56,406
|
52,474
|
53,177
|
54,378
|
55,553
|
|
Total Current Liabilities |
20,405
|
20,684
|
18,586
|
19,467
|
15,555
|
17,583
|
|
Long Term Debt |
40,125
|
35,722
|
33,888
|
33,710
|
38,823
|
37,970
|
|
Shareholder equity |
29,186
|
26,838
|
32,422
|
38,248
|
43,744
|
45,587
|
|
Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Cash from Operations |
11,041
|
12,238
|
11,349
|
6,064
|
10,990
|
7,257
|
|
Depreciation |
3,657
|
3,714
|
4,688
|
4,694
|
5,846
|
6,388
|
|
Cash from Investing |
-5,428
|
312
|
2,078
|
174
|
-1,264
|
3,063
|
|
Capex |
4,307
|
3,265
|
2,401
|
1,724
|
1,556
|
1,280
|
|
Cash from Financing |
-6,215
|
-12,416
|
-13,379
|
-6,198
|
-9,473
|
-12,753
|
|
Stock Issued |
-2,246
|
-9,189
|
-4,381
|
-2,698
|
-2,758
|
-4,012
|
|
Debt (LT) Issued |
2,336
|
2,616
|
-3,503
|
1,831
|
-1,492
|
-3,495
|
|
Free Cash Flow |
10,612
|
9,774
|
-2,086
|
9,640
|
7,426
|
851
|
|
Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Net Profit Margin |
24.3%
|
20.3%
|
8.0%
|
7.2%
|
13.8%
|
27.1%
|
|
NCFO / Op.Income |
86.8%
|
104.2%
|
155.1%
|
199.7%
|
140.5%
|
113.7%
|
|
Current Ratio |
1.3
|
1.3
|
1.4
|
1.4
|
1.9
|
1.6
|
|
Financial Leverage D/E |
0.98
|
0.97
|
0.73
|
0.71
|
0.57
|
0.58
|
|
Return on Capital Avg |
19.1%
|
14.8%
|
-5.3%
|
4.4%
|
8.3%
|
3.7%
|
|
Return on Shareholder Equity |
41.1%
|
31.4%
|
9.5%
|
6.9%
|
12.3%
|
23.7%
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available